Promising New Ulcerative Colitis Therapy Revealed in COLLECT Trial Result

Promising New Ulcerative Colitis Therapy Revealed in COLLECT Trial Result
A research team led by Christopher Hawkey, a professor from Nottingham University Hospitals, U.K., reported promising results for a novel potential therapy for ulcerative colitis - cobitolimod. The study "Clinical effects of a topically applied Toll- receptor 9 agonist in active moderate to severe ulcerative colitis,published in the Journal of Crohn's and Colitis (JCC), investigated the drug's treatment potential in 131 patients. The study, called the 
Subscribe or to access all post and page content.